News Data keeps Lilly in race for new migraine treatment Company still in race to develop CGRP inhibitor for migraine.
Events Partner Content Data Integrity for Clinical Research Summit Data Integrity for Clinical Research Summit
News Valeant's Siliq price undercuts rivals to offset black box w... Siliq will be cheaper than rivals from Novartis and Eli Lilly.
News NHS proposes crackdown on erectile dysfunction drugs and sun... Eli Lilly's Cialis named on list of drugs no longer consider cost-effective.
News Novartis cues up Cosentyx as disease-modifying treatment for... Pharma begins early intervention trial after Cosentyx shows "disease modifying" properties
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
